Forage | $40,000,000 | (Jun 5, 2026)
InCharge Energy | $46,000,000 | (Jun 5, 2026)
Oak Hill Bio | $32,500,000 | (Jun 5, 2026)
Perpetual Medicines
China
- Shanghai
- 01/12/2023
- Seed
- $8,000,000
About Perpetual Medicines
Perpetual Medicines is a fully integrated computational peptide therapeutics company that aims to build the next-generation peptide drug discovery engine. Perpetual Medicines’ platform will combine leading-edge methods in computational physics including MD simulation, FEP, and quantum chemistry with next-generation AI technologies to predict numerous peptide properties with supreme accuracy. We will also couple this “dry” platform with large-scale synthetic laboratory using state-of-the-art biophysical and chemistry methods for high-throughput peptide synthesis & experimentation. Our vision is to disrupt the enormous 40bn-a-year peptide drug market by heralding in a new renaissance in peptide discovery, design & development.
- Industry Biotechnology Research
- Website https://perpetualmeds.com/index
- LinkedIn https://www.linkedin.com/company/perpetual-medicines/about/
Related People
Kerry BlanchardCo Founder
China -
Jing'an District, Shanghai
Drug discovery and development, cell cycle regulation and control, biology of hypoxia, epigenetics, cancer genetics, translational science
ZutaCore | $100,000,000 | (Jun 5, 2026)
Terra AI | $20,000,000 | (Jun 5, 2026)
Town | $55,000,000 | (Jun 5, 2026)
Lassie | $35,000,000 | (Jun 5, 2026)
OFFROAD | $7,000,000 | (Jun 5, 2026)
Shifters | $10,200,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
Scispot | $8,000,000 | (Jun 5, 2026)
Scotch | $20,000,000 | (Jun 5, 2026)